DermTech Q2 EPS $(0.99) Misses $(0.95) Estimate, Sales $3.56M Beat $3.55M Estimate
Portfolio Pulse from Benzinga Newsdesk
DermTech (NASDAQ:DMTK) reported Q2 losses of $(0.99) per share, missing the analyst consensus estimate of $(0.95) by 4.21%. However, the company's quarterly sales of $3.56 million beat the estimate of $3.55 million by 0.42%. This represents a 15.78% decrease in sales compared to the same period last year.
August 04, 2023 | 2:35 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
DermTech's Q2 earnings per share missed estimates, while sales slightly beat expectations. However, sales are down 15.78% compared to the same period last year.
DermTech's missed EPS estimate and decreased sales YoY could negatively impact investor sentiment, potentially leading to a short-term decrease in stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100